Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: Report of the third workshop of the molecular biology/BMT Study Group

Timothy P. Hughes, Achille Ambrosetti, Veronique Barbu, Claus Bartram, Raffaele Battista, Andrea Biondi, Andrea Chiamenti, Giuseppe Cimino, Peter Ernst, Francesco Frassoni, Paolo Gasparini, Ivo Gentilini, Eliane Gluckman, Gerard Grosveld, Angelo Guerrasio, Susan Hegewich, Johannes W G Janssen, Armand Keating, Francesco Lo Coco, Philippe MartiatGiovanni Martinelli, Ken Mills, Gareth Morgan, Gianpaolo Nadali, Pier Giussepe Pelicci, Giuseppe Perona, Pier Franco Pignatti, Patrice Richard, Giuseppe Saglio, Elisabetta Trabetti, Alberto Turco, Dino Veneri, Alfonso Zaccaria, Axel Zander, John M. Goldman

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The proceedings of the third workshop of the molecular biology/bone marrow transplantation (BMT) study group held in January 1991 in Verona, Italy. This workshop was convened to review progress in the application of molecular techniques to the diagnosis and follow-up of patients with chronic myeloid leukaemia (CML) as well as other haematologic malignancies. The results of polymerase chainreaction studies in 157 CML patients 1-90 months post BMT suggest that leukaemia is frequently detectable for the first 12 months but rarely detected thereafter except in patients known to have a high risk of relapse. In the acute leukaemias and lymphomas there is a rapidly increasing number of leukaemia-specific as well as clone-specific molecular markers now available for the detection of minimal disease. It may be possible to coordinate multi-center prospective studies to investigate the role of these markers in the diagnosis and follow-up of haematologic malignancies.

Original languageEnglish
Pages (from-to)448-451
Number of pages4
JournalLeukemia
Volume5
Issue number6
Publication statusPublished - Jun 1991

Fingerprint

Bone Marrow Transplantation
Molecular Biology
Lymphoma
Leukemia
Hematologic Neoplasms
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Education
Polymerase Chain Reaction
Italy
Clone Cells
Prospective Studies
Recurrence

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Hughes, T. P., Ambrosetti, A., Barbu, V., Bartram, C., Battista, R., Biondi, A., ... Goldman, J. M. (1991). Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: Report of the third workshop of the molecular biology/BMT Study Group. Leukemia, 5(6), 448-451.

Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma : Report of the third workshop of the molecular biology/BMT Study Group. / Hughes, Timothy P.; Ambrosetti, Achille; Barbu, Veronique; Bartram, Claus; Battista, Raffaele; Biondi, Andrea; Chiamenti, Andrea; Cimino, Giuseppe; Ernst, Peter; Frassoni, Francesco; Gasparini, Paolo; Gentilini, Ivo; Gluckman, Eliane; Grosveld, Gerard; Guerrasio, Angelo; Hegewich, Susan; Janssen, Johannes W G; Keating, Armand; Lo Coco, Francesco; Martiat, Philippe; Martinelli, Giovanni; Mills, Ken; Morgan, Gareth; Nadali, Gianpaolo; Pelicci, Pier Giussepe; Perona, Giuseppe; Pignatti, Pier Franco; Richard, Patrice; Saglio, Giuseppe; Trabetti, Elisabetta; Turco, Alberto; Veneri, Dino; Zaccaria, Alfonso; Zander, Axel; Goldman, John M.

In: Leukemia, Vol. 5, No. 6, 06.1991, p. 448-451.

Research output: Contribution to journalArticle

Hughes, TP, Ambrosetti, A, Barbu, V, Bartram, C, Battista, R, Biondi, A, Chiamenti, A, Cimino, G, Ernst, P, Frassoni, F, Gasparini, P, Gentilini, I, Gluckman, E, Grosveld, G, Guerrasio, A, Hegewich, S, Janssen, JWG, Keating, A, Lo Coco, F, Martiat, P, Martinelli, G, Mills, K, Morgan, G, Nadali, G, Pelicci, PG, Perona, G, Pignatti, PF, Richard, P, Saglio, G, Trabetti, E, Turco, A, Veneri, D, Zaccaria, A, Zander, A & Goldman, JM 1991, 'Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: Report of the third workshop of the molecular biology/BMT Study Group', Leukemia, vol. 5, no. 6, pp. 448-451.
Hughes, Timothy P. ; Ambrosetti, Achille ; Barbu, Veronique ; Bartram, Claus ; Battista, Raffaele ; Biondi, Andrea ; Chiamenti, Andrea ; Cimino, Giuseppe ; Ernst, Peter ; Frassoni, Francesco ; Gasparini, Paolo ; Gentilini, Ivo ; Gluckman, Eliane ; Grosveld, Gerard ; Guerrasio, Angelo ; Hegewich, Susan ; Janssen, Johannes W G ; Keating, Armand ; Lo Coco, Francesco ; Martiat, Philippe ; Martinelli, Giovanni ; Mills, Ken ; Morgan, Gareth ; Nadali, Gianpaolo ; Pelicci, Pier Giussepe ; Perona, Giuseppe ; Pignatti, Pier Franco ; Richard, Patrice ; Saglio, Giuseppe ; Trabetti, Elisabetta ; Turco, Alberto ; Veneri, Dino ; Zaccaria, Alfonso ; Zander, Axel ; Goldman, John M. / Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma : Report of the third workshop of the molecular biology/BMT Study Group. In: Leukemia. 1991 ; Vol. 5, No. 6. pp. 448-451.
@article{61c0d0bd27824e87adb2d1417a3cde3c,
title = "Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: Report of the third workshop of the molecular biology/BMT Study Group",
abstract = "The proceedings of the third workshop of the molecular biology/bone marrow transplantation (BMT) study group held in January 1991 in Verona, Italy. This workshop was convened to review progress in the application of molecular techniques to the diagnosis and follow-up of patients with chronic myeloid leukaemia (CML) as well as other haematologic malignancies. The results of polymerase chainreaction studies in 157 CML patients 1-90 months post BMT suggest that leukaemia is frequently detectable for the first 12 months but rarely detected thereafter except in patients known to have a high risk of relapse. In the acute leukaemias and lymphomas there is a rapidly increasing number of leukaemia-specific as well as clone-specific molecular markers now available for the detection of minimal disease. It may be possible to coordinate multi-center prospective studies to investigate the role of these markers in the diagnosis and follow-up of haematologic malignancies.",
author = "Hughes, {Timothy P.} and Achille Ambrosetti and Veronique Barbu and Claus Bartram and Raffaele Battista and Andrea Biondi and Andrea Chiamenti and Giuseppe Cimino and Peter Ernst and Francesco Frassoni and Paolo Gasparini and Ivo Gentilini and Eliane Gluckman and Gerard Grosveld and Angelo Guerrasio and Susan Hegewich and Janssen, {Johannes W G} and Armand Keating and {Lo Coco}, Francesco and Philippe Martiat and Giovanni Martinelli and Ken Mills and Gareth Morgan and Gianpaolo Nadali and Pelicci, {Pier Giussepe} and Giuseppe Perona and Pignatti, {Pier Franco} and Patrice Richard and Giuseppe Saglio and Elisabetta Trabetti and Alberto Turco and Dino Veneri and Alfonso Zaccaria and Axel Zander and Goldman, {John M.}",
year = "1991",
month = "6",
language = "English",
volume = "5",
pages = "448--451",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma

T2 - Report of the third workshop of the molecular biology/BMT Study Group

AU - Hughes, Timothy P.

AU - Ambrosetti, Achille

AU - Barbu, Veronique

AU - Bartram, Claus

AU - Battista, Raffaele

AU - Biondi, Andrea

AU - Chiamenti, Andrea

AU - Cimino, Giuseppe

AU - Ernst, Peter

AU - Frassoni, Francesco

AU - Gasparini, Paolo

AU - Gentilini, Ivo

AU - Gluckman, Eliane

AU - Grosveld, Gerard

AU - Guerrasio, Angelo

AU - Hegewich, Susan

AU - Janssen, Johannes W G

AU - Keating, Armand

AU - Lo Coco, Francesco

AU - Martiat, Philippe

AU - Martinelli, Giovanni

AU - Mills, Ken

AU - Morgan, Gareth

AU - Nadali, Gianpaolo

AU - Pelicci, Pier Giussepe

AU - Perona, Giuseppe

AU - Pignatti, Pier Franco

AU - Richard, Patrice

AU - Saglio, Giuseppe

AU - Trabetti, Elisabetta

AU - Turco, Alberto

AU - Veneri, Dino

AU - Zaccaria, Alfonso

AU - Zander, Axel

AU - Goldman, John M.

PY - 1991/6

Y1 - 1991/6

N2 - The proceedings of the third workshop of the molecular biology/bone marrow transplantation (BMT) study group held in January 1991 in Verona, Italy. This workshop was convened to review progress in the application of molecular techniques to the diagnosis and follow-up of patients with chronic myeloid leukaemia (CML) as well as other haematologic malignancies. The results of polymerase chainreaction studies in 157 CML patients 1-90 months post BMT suggest that leukaemia is frequently detectable for the first 12 months but rarely detected thereafter except in patients known to have a high risk of relapse. In the acute leukaemias and lymphomas there is a rapidly increasing number of leukaemia-specific as well as clone-specific molecular markers now available for the detection of minimal disease. It may be possible to coordinate multi-center prospective studies to investigate the role of these markers in the diagnosis and follow-up of haematologic malignancies.

AB - The proceedings of the third workshop of the molecular biology/bone marrow transplantation (BMT) study group held in January 1991 in Verona, Italy. This workshop was convened to review progress in the application of molecular techniques to the diagnosis and follow-up of patients with chronic myeloid leukaemia (CML) as well as other haematologic malignancies. The results of polymerase chainreaction studies in 157 CML patients 1-90 months post BMT suggest that leukaemia is frequently detectable for the first 12 months but rarely detected thereafter except in patients known to have a high risk of relapse. In the acute leukaemias and lymphomas there is a rapidly increasing number of leukaemia-specific as well as clone-specific molecular markers now available for the detection of minimal disease. It may be possible to coordinate multi-center prospective studies to investigate the role of these markers in the diagnosis and follow-up of haematologic malignancies.

UR - http://www.scopus.com/inward/record.url?scp=0025829828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025829828&partnerID=8YFLogxK

M3 - Article

C2 - 2056768

AN - SCOPUS:0025829828

VL - 5

SP - 448

EP - 451

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 6

ER -